SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 1,564.23 |
Enterprise Value ($M) | 1,190.19 |
Book Value ($M) | 469.08 |
Book Value / Share | 2.94 |
Price / Book | 3.33 |
NCAV ($M) | 451.16 |
NCAV / Share | 2.83 |
Price / NCAV | 3.47 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.54 |
Return on Assets (ROA) | -0.65 |
Return on Equity (ROE) | -0.69 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 19.05 |
Current Ratio | 19.05 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 478.28 |
Assets | 496.19 |
Liabilities | 27.12 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -188.19 |
Net Income | -235.93 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -163.28 |
Cash from Investing | 64.39 |
Cash from Financing | 231.94 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Berns Paul L | 5.20 | ||
13G | Softbank Group Corp | 5.00 | ||
13D/A | ARCH Venture Fund XII, L.P. | 20.90 | 7.28 | |
13D | Amgen Inc | 23.20 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
104,219 | 395,980 | 26.32 | |
92,937 | 460,130 | 20.20 | |
122,373 | 169,797 | 72.07 | |
85,724 | 378,385 | 22.66 | |
(click for more detail) |
Similar Companies | |
---|---|
NBIX – Neurocrine Biosciences, Inc. | NEOG – Neogen Corporation |
NKTX – Nkarta, Inc. | NUVL – Nuvalent, Inc. |
NVAX – Novavax, Inc. |
Financial data and stock pages provided by
Fintel.io